Referências

1. American Psychiatric Association, 2000, DIAGN STAT MAN MENT
2. Fleeman N, 2011, PHARMACOGENOMICS J, V11, P1, DOI 10.1038/tpj.2010.73
3. LLerena A, 2007, PHARMACOGENOMICS J, V7, P408, DOI 10.1038/sj.tpj.6500439
4. Sabbagh A, 2006, HUM HERED, V62, P119, DOI 10.1159/000096416
5. Kirchheiner J, 2004, MOL PSYCHIATR, V9, P442, DOI 10.1038/sj.mp.4001494
6. Dahl AA, 1998, HUM PSYCHOPHARM CLIN, V13, P509, DOI 10.1002/(SICI)1099-1077(1998100)13:7<509::AID-HUP32>3.3.CO;2-T
7. Ragia G, 2009, PHARMACOGENOMICS, V10, P43, DOI 10.2217/14622416.10.1.43
8. Bernard S, 2006, ONCOLOGIST, V11, P126, DOI 10.1634/theoncologist.11-2-126
9. Sistonen J, 2007, PHARMACOGENET GENOM, V17, P93
10. Brockmoller J, 2002, CLIN PHARMACOL THER, V72, P438, DOI 10.1067/mcp.2002.127494
11. Arranz MJ, 2007, MOL PSYCHIATR, V12, P707, DOI 10.1038/sj.mp.4002009
12. International Psychopharmacology Algorithm Project, 2006, IPAP SCHIZ ALG DOWNL